Skip to main content
Erschienen in: Pituitary 3/2013

01.09.2013

Evaluation of depression, quality of life and body image in patients with Cushing’s disease

verfasst von: Nilufer Alcalar, Sedat Ozkan, Pinar Kadioglu, Ozlem Celik, Penbe Cagatay, Baris Kucukyuruk, Nurperi Gazioglu

Erschienen in: Pituitary | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate patients with Cushing’s disease (CD) who had undergone transsphenoidal surgery in terms of depression, quality of life (QoL), and perception of body image in comparison to healthy controls. Forty patients with CD and 40 healthy controls matched for demographic characteristics were included in the study. The subjects were evaluated with the Beck depression inventory (BDI), the health survey-short form (SF-36) and the multidimensional body-self relations questionnaire (MBSRQ). Subgroups of the patients with CD were formed on the basis of remission status and BDI scores. In this study, QoL in the general health category and body image were lower in the patients with CD than in the healthy subjects. However, no differences in depression scores were found between the two groups. When the CD group was evaluated according to remission rate, the mean BDI score was significantly higher in the CD patients without remission than in both the CD patients with remission and the healthy subjects (p = 0.04). However, the physical functioning, bodily pain and general health scores of the CD patients without remission on the SF-36 questionnaire were lower than in the CD patients in remission and the healthy subjects (p = 0.002, p = 0.04, p = 0.002, respectively). Fitness evaluation, health evaluation and body areas satisfaction scores of the MBSRQ were significantly different in the three groups (p = 0.003, p = 0.009 and p = 0.001, respectively). In this study, patients with CD were found to have lower QoL, lower body image perception and higher levels of depression compared to healthy controls, particularly if the disease is persistant despite surgery.
Literatur
1.
Zurück zum Zitat Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623CrossRefPubMed Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623CrossRefPubMed
2.
Zurück zum Zitat Pivonello R, De Leo MC, De Leo M, Lombardi G, Colao A (2008) Cushing’s Syndrome. Endocrinol Metab Clin N Am 37:135–149CrossRef Pivonello R, De Leo MC, De Leo M, Lombardi G, Colao A (2008) Cushing’s Syndrome. Endocrinol Metab Clin N Am 37:135–149CrossRef
3.
Zurück zum Zitat Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müler OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108:9–18CrossRefPubMed Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müler OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108:9–18CrossRefPubMed
4.
Zurück zum Zitat Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER (2008) Late recurrences of Cushing’s disease after ınitial successful transsphenoidal surgery. J Clin Endocrinol Metab 93:358–362CrossRefPubMed Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER (2008) Late recurrences of Cushing’s disease after ınitial successful transsphenoidal surgery. J Clin Endocrinol Metab 93:358–362CrossRefPubMed
5.
Zurück zum Zitat Mancini T, Porcelli T, Giustina A (2010) Treatment of Cushing’s disease: overview and recent findings. Ther Clin Risk Manag 6:505–516PubMed Mancini T, Porcelli T, Giustina A (2010) Treatment of Cushing’s disease: overview and recent findings. Ther Clin Risk Manag 6:505–516PubMed
6.
Zurück zum Zitat Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F (1998) Clinical correlates of major depression in Cushing’s disease. Psychopathology 31:302–306CrossRefPubMed Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F (1998) Clinical correlates of major depression in Cushing’s disease. Psychopathology 31:302–306CrossRefPubMed
7.
Zurück zum Zitat Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed
8.
Zurück zum Zitat Van Aken MO, Pereira AM, Biermasz NR, Van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SWJ, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metab 90:3279–3286CrossRefPubMed Van Aken MO, Pereira AM, Biermasz NR, Van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SWJ, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metab 90:3279–3286CrossRefPubMed
9.
Zurück zum Zitat Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing’s disease. Rev Endocr Metab Disord 11:95–104CrossRefPubMed Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing’s disease. Rev Endocr Metab Disord 11:95–104CrossRefPubMed
10.
Zurück zum Zitat Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman KL (2006) Long-term ımpaired quality of life in Cushing’s syndrome despite ınitial ımprovement after surgical remission. J Clin Endocrinol Metab 91:447–453CrossRefPubMed Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman KL (2006) Long-term ımpaired quality of life in Cushing’s syndrome despite ınitial ımprovement after surgical remission. J Clin Endocrinol Metab 91:447–453CrossRefPubMed
11.
Zurück zum Zitat Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing’s disease: a 10-Year experience. Ann Surg 245:790–794CrossRefPubMed Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing’s disease: a 10-Year experience. Ann Surg 245:790–794CrossRefPubMed
12.
Zurück zum Zitat Sonino N, Fava GA (1998) Psychological aspects of endocrine disease. Clin Endocrinol (Oxf) 49:1–7CrossRef Sonino N, Fava GA (1998) Psychological aspects of endocrine disease. Clin Endocrinol (Oxf) 49:1–7CrossRef
13.
Zurück zum Zitat Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 61:458–465CrossRef Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 61:458–465CrossRef
14.
Zurück zum Zitat Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. Q J Med 89:543–551CrossRef Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. Q J Med 89:543–551CrossRef
15.
Zurück zum Zitat Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, Van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol 58:623–630CrossRef Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, Van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol 58:623–630CrossRef
16.
Zurück zum Zitat Bech P, Gudex C, Staehr Johansen K (1996) The WHO (ten) well-being index: validation in diabetes. Psychother Psychosom 65:183–190CrossRefPubMed Bech P, Gudex C, Staehr Johansen K (1996) The WHO (ten) well-being index: validation in diabetes. Psychother Psychosom 65:183–190CrossRefPubMed
17.
18.
Zurück zum Zitat Nieman LK, Biler BMK, Findling JW, Newell Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540CrossRefPubMed Nieman LK, Biler BMK, Findling JW, Newell Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540CrossRefPubMed
19.
Zurück zum Zitat Beck AT, Ward Ch, Mendelson M, Mosk J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed Beck AT, Ward Ch, Mendelson M, Mosk J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
20.
Zurück zum Zitat Cohen SI (1980) Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120–124CrossRefPubMed Cohen SI (1980) Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120–124CrossRefPubMed
21.
Zurück zum Zitat Loosen PT, Chamliss B, Debold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 25:192–198CrossRefPubMed Loosen PT, Chamliss B, Debold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 25:192–198CrossRefPubMed
22.
Zurück zum Zitat Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M (1998) Risk factors and long term outcome in pituitary-dependent Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M (1998) Risk factors and long term outcome in pituitary-dependent Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed
23.
Zurück zum Zitat Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing’s syndrome. CNS Drugs 15:361–373CrossRefPubMed Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing’s syndrome. CNS Drugs 15:361–373CrossRefPubMed
24.
Zurück zum Zitat Kelly WF, Checkley SA, Bender DA (1980) Cushing’s syndrome, tryptophan and depression. Br J Psychiatry 136:125–132CrossRefPubMed Kelly WF, Checkley SA, Bender DA (1980) Cushing’s syndrome, tryptophan and depression. Br J Psychiatry 136:125–132CrossRefPubMed
25.
Zurück zum Zitat Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s disease. J Clin Endocrinol Metab 95(12):E129–E141CrossRefPubMed Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s disease. J Clin Endocrinol Metab 95(12):E129–E141CrossRefPubMed
26.
Zurück zum Zitat Jeffcoate WJ, Silverstone JT, Edwars CR, Beser GM (1979) Psychiatric manifestations of Cushing’s syndrome: response to lowering of plasma cortisol. Q J Med 48:465–472PubMed Jeffcoate WJ, Silverstone JT, Edwars CR, Beser GM (1979) Psychiatric manifestations of Cushing’s syndrome: response to lowering of plasma cortisol. Q J Med 48:465–472PubMed
27.
Zurück zum Zitat Castinetti F, Fassnacht M, Johanssen S, Terzolo M, Bouchard P, Chanson P, Do Cao C, Morange I, Pico A, Ouzounian S, Young J, Hahner S, Brue T, Allolio B, Conte-Devolx B (2009) Merits and pitfalls of mifepristone in Cushing’s syndrome. Eur J Endocrinol 160:1003–1010CrossRefPubMed Castinetti F, Fassnacht M, Johanssen S, Terzolo M, Bouchard P, Chanson P, Do Cao C, Morange I, Pico A, Ouzounian S, Young J, Hahner S, Brue T, Allolio B, Conte-Devolx B (2009) Merits and pitfalls of mifepristone in Cushing’s syndrome. Eur J Endocrinol 160:1003–1010CrossRefPubMed
28.
Zurück zum Zitat Starkman MN, Schteingart DE, Schork MA (1986) Cushing’s syndrome after treatment: changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res 19:177–188CrossRefPubMed Starkman MN, Schteingart DE, Schork MA (1986) Cushing’s syndrome after treatment: changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res 19:177–188CrossRefPubMed
29.
Zurück zum Zitat Dorn LD, Burgess ES, Friedman T, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919CrossRefPubMed Dorn LD, Burgess ES, Friedman T, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919CrossRefPubMed
30.
Zurück zum Zitat Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing’s syndrome. Clin Endocrinol 64:314–318CrossRef Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing’s syndrome. Clin Endocrinol 64:314–318CrossRef
31.
Zurück zum Zitat Van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, Van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease specific impairments in quality of life during long term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69:775–784CrossRef Van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, Van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease specific impairments in quality of life during long term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69:775–784CrossRef
32.
Zurück zum Zitat Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with pituitary adenoma. Pituitary 6:81–87CrossRefPubMed Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with pituitary adenoma. Pituitary 6:81–87CrossRefPubMed
33.
Zurück zum Zitat Lindholm J, Juul S, Jorgenson JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population –based study. J Clin Endocrinol Metab 86:117–123CrossRefPubMed Lindholm J, Juul S, Jorgenson JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population –based study. J Clin Endocrinol Metab 86:117–123CrossRefPubMed
34.
Zurück zum Zitat Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after bilateral adrenalectomy for Cushing’s disease. Surgery 132:1064–1068CrossRefPubMed Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after bilateral adrenalectomy for Cushing’s disease. Surgery 132:1064–1068CrossRefPubMed
35.
Zurück zum Zitat Tiemensma J, Daskalakis NP, van der Veen EM, Ramondt S, Richardson SK, Broadbent E, Romijn JA, Pereira AM, Biermasz NR, Kaptein AA (2012) Drawings reflect a new dimension of the psychological ımpact of long-term remission of Cushing’s syndrome. J Clin Endocrinol Metab. (Epub ahead of print) Tiemensma J, Daskalakis NP, van der Veen EM, Ramondt S, Richardson SK, Broadbent E, Romijn JA, Pereira AM, Biermasz NR, Kaptein AA (2012) Drawings reflect a new dimension of the psychological ımpact of long-term remission of Cushing’s syndrome. J Clin Endocrinol Metab. (Epub ahead of print)
Metadaten
Titel
Evaluation of depression, quality of life and body image in patients with Cushing’s disease
verfasst von
Nilufer Alcalar
Sedat Ozkan
Pinar Kadioglu
Ozlem Celik
Penbe Cagatay
Baris Kucukyuruk
Nurperi Gazioglu
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 3/2013
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-012-0425-5

Weitere Artikel der Ausgabe 3/2013

Pituitary 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.